FDA, FTC Join Forces To Eliminate Barriers To Biosimilar Competition

 
• By Brenda Sandburg
Conceptual business illustration with the words anti-competitive practices
FDA and FTC to target anticompetitive behavior that impedes access to biosimilars

More from Biosimilars

More from Biosimilars & Generics